Profil
William C.
Roberts is currently VP-Investor Relations & Corporate Communications at G1 Therapeutics, Inc. since 2021 and SVP-Corporate Communications & Investor Relations at Aclaris Therapeutics, Inc. starting in 2025.
Former positions include Vice President-Communications & Investor Relations at Shire ViroPharma, Inc., Vice President-Investor Relations & Communications at Harmony Biosciences Management, Inc., Head-Investor Relations at MedImmune LLC, Vice President-Investor Relations at Adaptimmune Therapeutics Plc, and Vice President-Corporate Communications at Viropharma, Inc. Education includes undergraduate studies at the University of Virginia and an MBA from Keller Graduate School of Management.
Postes actifs de William C. Roberts
| Sociétés | Poste | Début |
|---|---|---|
| G1 THERAPEUTICS, INC. | Investor Relations Contact | 04/01/2021 |
| ACLARIS THERAPEUTICS, INC. | Investor Relations Contact | 01/01/2025 |
Anciens postes connus de William C. Roberts
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Investor Relations Contact | 23/10/2017 |
Viropharma, Inc. | Public Communications Contact | - |
| ZYNERBA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Investor Relations Contact | - |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Investor Relations Contact | - |
Formation de William C. Roberts
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keller Graduate School of Management
Keller Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Viropharma, Inc. |
















